Evoke Pharma Inc (EVOK)
5.09
-0.40
(-7.29%)
USD |
NASDAQ |
Dec 20, 16:00
5.02
-0.07
(-1.38%)
After-Hours: 20:00
Evoke Pharma Profit Margin (Quarterly): -49.45% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 8.48% |
| MEI Pharma Inc | -- |
| Revance Therapeutics Inc | -63.65% |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -433.1% |
| Return on Assets | -57.27% |
| Return on Invested Capital | -95.76% |
| Gross Profit Margin (Quarterly) | 96.08% |
| Operating Margin (Quarterly) | -48.44% |